UGC Approved Journal no 63975(19)
New UGC Peer-Reviewed Rules

ISSN: 2349-5162 | ESTD Year : 2014
Volume 13 | Issue 3 | March 2026

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 10 Issue 5
May-2023
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2305033


Registration ID:
514076

Page Number

a229-a245

Share This Article


Jetir RMS

Title

A Brief Review on Regulatory Approaches of Pharma Industry

Abstract

The pharmaceutical industry has always established keep intent to produce drug products with enhanced quality for meeting the patient requirement. The consistent invention of drug products with the desired quality traits, however, has been an arduous challenge owing to the prevalence of high degree of unpredictability in active pharmaceutical ingredients, raw materials, and/or processes. In an endeavor to address such crucial issues, the pharma houses have lately been undergoing transformation by adopting systematic approach for developing drug product with enhanced quality, robustness and resource-economics. Robust regulatory arrangement provides the foundation for a national method of medicine safety, and for public self-assurance in medicines. This article focuses on the need to sharpen the regulatory requirement for pharmacovigilance in India. To be operative the responsibility of drug regulatory authorities needs to go further than the approval of new medicines, to encompass a wider range of issues related to the safety of medicine. In order to achieve their respective objective pharmacovigilance program and drug regulatory authorities must be mutually supporting. Quality risk management (QRM) is one of the most important tasks when it comes to the pharmaceutical industry. It is because the industry produces medicines, whose quality is directly related to the patient’s health. The International Conference on Harmonization (ICH) has developed various guidelines to guard the quality of medicines along with its safety and efficacy. QRM is currently approaching to be a required practice in industries.

Key Words

Cite This Article

"A Brief Review on Regulatory Approaches of Pharma Industry", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 5, page no.a229-a245, May-2023, Available :http://www.jetir.org/papers/JETIR2305033.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"A Brief Review on Regulatory Approaches of Pharma Industry", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 5, page no. ppa229-a245, May-2023, Available at : http://www.jetir.org/papers/JETIR2305033.pdf

Publication Details

Published Paper ID: JETIR2305033
Registration ID: 514076
Published In: Volume 10 | Issue 5 | Year May-2023
DOI (Digital Object Identifier):
Page No: a229-a245
Country: Ahmednagar , Maharashtra , India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000260

Print This Page

Current Call For Paper

Jetir RMS